NEUROIMMUNE MODULATION FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Monday, November 9, 2026
2:30-3:15 PM EST
ACR Innovation Theater
Join us for a review of the mechanism of action behind SetPoint Therapy and the latest 2-year efficacy and safety results from RESET-RA Study.